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sditor’s Note
ue to communication problems, several Letters to the
ditor were misplaced and were not published in a timely
ashion. We became aware of this recently when one of
he authors contacted us as to the publication status. We
ave gathered those letters together and are now pub-
ishing them in this issue. In general, we believe that the
etters and the replies are self explanatory. We apologize
or this delay.
he CHARM of a Paradox
he paradox in the CHARM (Candesartan in Heart Failure:
ssessment of Reduction in Mortality and Morbidity) study (1)
eeds to be explained if low brachial systolic pressure is perceived
y physicians as a contraindication to the use of arterial dilator
rugs such as nitrates, carvedilol, and candesartan in systolic heart
ailure. Meredith et al. (1) extended results of previous studies
AHeFT [African-American Heart Failure Trial (2)] and
OPERNICUS [Carvedilol Prospective Randomized Cumulative
urvival (3)]) in showing that an arterial vasodilator was at least as
ffective in trials of cardiac failure for improving outcomes in
atients with systolic blood pressure (SBP) 100 mm Hg (whose
eft ventricular ejection fraction averaged 25%) as in those with
ormal or high SBP and without appreciable risk of causing
ymptomatic hypotension.
The paradox arises from exclusive consideration of brachial
ather than central pressure (4) and from assuming that effects of
ilator drugs on high-resistance arterioles dominate over effects on
ow-resistance conduit arteries. Arterial vasodilator drugs such as
itroglycerin reduce wave reflection (5,6) and “trap” reflected
ressure waves in the peripheral circulation so that they do not
ummate with central systolic pressure, with this differentially
educed compared with brachial SBP (4,6). In patients with a low
eft ventricular ejection fraction and the ventricle contracting
eakly and acting (in engineering terms) as a “pressure source”
6,7), reduction in aortic and left ventricular systolic pressure leads
o increased left ventricular ejection from the heart (6,7). Such an
ncrease in stroke volume can maintain or increase SBP in patients
ith cardiac failure due to systolic dysfunction.
The paradox described by Meredith et al. (1) is explicable. It
xplains why drugs that dilate muscular arteries and reduce wave
eflection are very effective for reducing systolic pressure in
ypertension when the heart is contracting normally (i.e., as a flow
ource) (6,7) and for increasing cardiac output in patients with
eart failure when the heart’s contraction is weakened, and it acts
s a pressure source (6,7).
Consideration of blood pressure, cardiac output, and peripheral
esistance is insufficient to explain the function of the pulsating
eart and blood vessels. These comments are offered without any
riticism of the excellent work of Meredith et al. (1). pMichael F. O’Rourke, DSc, MD
St. Vincent’s Clinic
38 Victoria Street, Suite 810
arlinghurst, Sydney NSW 2010
ustralia
-mail: m.orourke@unsw.edu.au
doi:10.1016/j.jacc.2009.01.085
lease note: Dr. O’Rourke is the founding director of AtCor Medical, Sydney,
ustralia, maker of a pulse-wave analysis system.
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ardiac Resynchronization
n Mildly Symptomatic
eart Failure and
symptomatic Patients
read with interest the results of the REVERSE (REsynchroni-
ation reVErses Remodeling in Systolic left vEntricular dysfunc-
ion) trial in the paper by Linde et al. (1). The trial concluded that
ardiac resynchronization therapy, in combination with optimal
edical therapy, reduces the risk of heart failure hospitalization
nd improves ventricular structure and function in New York
eart Association functional class I and II patients with previous
eart failure symptoms. I think that it is worth noting that the
tudied population was composed of patients having significantly
rolonged QRS duration (average 156 ms) as well as quite severe
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January 19, 2010:255–69ilated left ventricular end-diastolic dimensions (average 70 mm).
ence, one should be careful when considering these results in the
eart failure patients of New York Heart Association functional
lasses I and II.
Sumer K. Dhir, MD
Boca Raton Community Hospital
284 Ketay Circle
oca Raton, Florida 33428-1516
-mail: sumerdhir@yahoo.com
doi:10.1016/j.jacc.2009.01.086
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edox Regulation of
ost-Prandial Vascular
ndothelial Dysfunction
rophylactic Benefits
f High-Intensity Exercise
yldum et al. (1) elegantly demonstrated that an acute bout of
igh-intensity interval exercise (HIE) provides superior prophy-
axis against post-prandial vascular endothelial dysfunction com-
ared with an isocaloric bout of continuous moderate-intensity
xercise. The post-prandial maintenance of brachial artery flow-
ediated vasodilation was attributed to an enhanced mobilization
f antioxidants into the systemic circulation, which was shown to
e exercise-intensity dependent. The authors speculated that by
eutralizing lipemia-induced oxidative stress, HIE preserved en-
othelial function subsequent to an increase in vascular nitric oxide
NO) bioavailability. Given the limited assessment of free radical
etabolism, I would like to raise some additional points for
onsideration and indeed proffer an alternative interpretation at
east for their metabolic findings.
The authors referred to our study, which documented an
xercise-induced mobilization of lipid soluble antioxidants into
uman skeletal muscle (2). Within the context of their observed
IE-induced increase in (blood borne) total antioxidant status,
his was taken as evidence that “acute [HIE] exercise tends to tip
he pro- and antioxidant balance in favor of increased antioxidant
tatus.” However, this interpretation is incorrect because multiple
iomarkers of free radical–mediated lipid peroxidation, end point
eterminants of oxidative stress (regardless of the antioxidant
esponse), were shown to increase markedly. Thus, the exercise-
nduced mobilization of antioxidants into both muscle and blood
erves to limit, although clearly not terminate, oxidative stress,
hich, despite the body’s best (antioxidant) efforts, ultimately
revails.Furthermore, increased vascular lipid free radical formation
oes not necessarily translate into reduced endothelial NO bio-
vailability (3). Whether the observed elevation in total antioxidant
tatus illustrated in Figure 2 of Tyldum et al. (1) (150 mol
ompared with the continuous moderate-intensity exercise trial,
hich, in contrast, was characterized by impaired endothelial
unction) was sufficient to outcompete “inactivating species” such
s superoxide (O2
·  NO· ¡ ONOO, k  109 M/s) to
iberate an “additional” pocket of (endothelial) NO is also from a
hermodynamic standpoint questionable given the pharmacologi-
al concentrations of (for example) ascorbate required to achieve
uch an effect (1 mM, which equates to roughly 20-fold the
mbient plasma concentration). Finally, I would argue that it is the
ate of antioxidant depletion that is more important than the
bsolute baseline concentration because it likely reflects the dy-
amics of consumption due to the sacrificial scavenging of free
adicals. Thus, if anything, the HIE (and indeed the continuous
oderate-intensity exercise) group exhibited a blunted antioxidant
esponse compared with the control (no exercise) group.
Is it conceivable, given that the antioxidants were confined to
he intravascular space, that the exercise intensity-dependent
levation in plasma total antioxidant status does not represent a
riming of the body’s endogenous antioxidant defenses but is
erely a hemoconcentration artifact subsequent to plasma volume
oss (4), further perpetuated by food intake? As little as 30 s of
igh-intensity exercise has been shown to depress plasma volume
or as long as 24 h into recovery, which, incidentally, was
ssociated with increased oxidative stress despite the blood’s best
fforts to elevate retinol and -tocopherol (5). Although the
uperior cardioprotection afforded by HIE is indeed a fascinating
nd truly novel finding, further research is required to establish
hether this is due to altered redox homeostasis.
Damian M. Bailey, PhD
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aculty of Health, Science and Sport
niversity of Glamorgan
id-Glamorgan, South Wales CF37 1DL
nited Kingdom
-mail: O2radical@btinternet.com
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